With the holiday season in full swing, it’s hard not to reflect on this past year and realize how thankful Veristat is to play such an instrumental role in the world of clinical research.
Every day, we are continually motivated to guide our clients as they navigate the challenges in their clinical development projects. Why? Because, there is nothing more special than seeing the real-life results of our work.
In 2017 alone, four novel therapies that Veristat worked on received regulatory approval by the FDA. Just these four approvals have had a profound impact to the patients who now have life-extending or even life-saving therapies that were not been available to them before.
At Veristat, we feel so fortunate to be a part of bringing medical innovations to the patients who need them so badly.
Let's Continue to Make A Difference This Holiday Season By Funding Research Breakthroughs to Beat Rare Cancers!
In this season of giving, Veristat has decided to #jointhebattle by donating and raising money to fund rare cancer research, instead of sending our employees, clients and clinical research partners holiday cards. Specifically, we have committed to donating and raising $35,000 for Cycle for Survival, one of the many organizations that we support each year.
Why We Support Cycle for Survival & The Movement to Beat Rare Cancers?
So far, 25 Breakthroughs Have Been Funded By Cycle for Survival!
Within six months of every Cycle for Survival event, donations are given to support bold research initiatives—empowering scientists and doctors to make lifesaving discoveries and advance trailblazing innovations that will help patients everywhere. In 2017, Cycle for Survival raised $34 million—which has funded the researchers and physicians who are making a lasting impact.
Donate Now! So far, Veristat is just over halfway to our fundraising goal and we want to overachieve this goal. Join the battle by helping us raise money for rare cancer research!